You’re Reading a Preview Become a Clinical Tree membership for Full access and enjoy Unlimited articles Become membership If you are a member. Log in here
You’re Reading a Preview Become a Clinical Tree membership for Full access and enjoy Unlimited articles Become membership If you are a member. Log in here
Open full size image KEY POINTS All patients should undergo screening for preexisting/concomitant cardiovascular (CV) risk factors, cancer-specific risks for cardiomyopathy, and previous cancer therapy-related risk factors for cardiomyopathy before initiation of cancer treatment. Cardiomyopathy or heart failure (CM/HF) can…